Brain metastases (BM) are a common and clinically significant manifestation of advanced cancer that increasingly influences treatment decisions across solid tumors. Management requires a tailored approach because intracranial disease may behave differently from extracranial disease, reflecting differences in drug penet...
Z. Sarfraz, R. Kotecha, Arun Maharaj et al.· Neurotherapeutics· 0 citations
Abstract Background Management of recurrent brain metastases (BM) remains a major clinical challenge, with limited effective salvage options and an increased risk of toxicity with re-irradiation. Intracranial brachytherapy has re-emerged as a focal treatment strategy, enabling localized dose escalation while minimizing...
Ruchit P. Jain, Namita Ruhela, K. Qidwai et al.· Neuro-Oncology Advances· 0 citations
In this prospective registry, resection followed by GammaTile brachytherapy achieved excellent local control, and manageable toxicity in newly diagnosed BM, supporting that GammaTile brachytherapy is a promising strategy for large or symptomatic BM.
Ruchit P. Jain, Z. Sarfraz, Mukesh Roy et al.· Neuro-Oncology Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
